Bruker's (BRKR) strong growth reflects its fundamental commitment to innovate high-value solutions and the ongoing portfolio transformation. Yet, the company’s operations bear the brunt of excessive currency exposure and general macroeconomic headwinds. The stock carries a Zacks Rank #3 (Hold) at present.The CALID segment has been gaining from the strong demand for differentiated instruments, particularly life science mass spectrometry proteomics solutions and optics spectroscopy and microscopy instruments. ...